Natural Product: NPC313452

Natural Product ID:  NPC313452
Common Name:   2,5,7-Trihydroxy-4-(4-Hydroxy-3,5-Dimethoxy-6-Methyloxan-2-Yl)Oxy-3,9-Dimethoxy-2-Methyl-3,4-Dihydrotetracene-1,6,11-Trione
IUPAC Name:   2,5,7-trihydroxy-4-(4-hydroxy-3,5-dimethoxy-6-methyloxan-2-yl)oxy-3,9-dimethoxy-2-methyl-3,4-dihydrotetracene-1,6,11-trione
Synonyms:  
Molecular Formula:   C29H32O13
Standard InCHIKey:  VHJWDTPKSIFZBV-UHFFFAOYSA-N
Standard InCHI:  InChI=1S/C29H32O13/c1-10-23(38-4)22(34)25(39-5)28(41-10)42-24-18-14(26(35)29(2,36)27(24)40-6)9-13-17(21(18)33)20(32)16-12(19(13)31)7-11(37-3)8-15(16)30/h7-10,22-25,27-28,30,33-34,36H,1-6H3
Canonical SMILES:  COC1C(OC(C(C1O)OC)C)OC1c2c(O)c3c(cc2C(=O)C(C1OC)(C)O)C(=O)c1c(C3=O)c(O)cc(c1)OC
First Find Year:  
Max Developmental Stage:  
Synthetic Gene Cluster:   ;

  Species Source

  Biological Activity

  Similar Natural Products in NPASS

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC313452 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

  Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC313452 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Structure

This browser does not support HTML5/Canvas.

External Identifiers

PubChem CID   99762
ChEMBL   CHEMBL2010354
ZINC  

Physicochemical Properties

Molecular Weight:  588.18
ALogP:  -3.1123
MLogP:  3.22
XLogP:  -1.604
# Rotatable Bonds:  16
Polar Surface Area:  187.51
# H-Bond Aceptor:  10
# H-Bond Donor:  4
# Rings:  5
# Heavy Atoms:  42

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs